Overview

Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial

Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy of golimumab with pamidronate in the treatment of axial spondyloarthropathy
Phase:
Phase 4
Details
Lead Sponsor:
Tuen Mun Hospital
Treatments:
Antibodies, Monoclonal
Golimumab
Pamidronate